The Study
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial.
This study is like a fair science experiment where people were randomly split into two groups: one got the new medicine and the other got a fake pill. It shows the medicine probably lowers bad cholesterol a lot, but we don’t know for sure if it prevents heart attacks.
Analysis score
Maximum 90 for a randomized controlled trial.
Where the score came from
Some people have very high bad cholesterol because of their genes. Even when they take cholesterol pills like statins, their levels stay too high. This study tested a new pill called enlicitide to see if it helps lower cholesterol even more.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 547 / 100
Quality score
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes, this is meaningful because lowering these cholesterol levels can reduce the risk of heart attacks and strokes in high-risk people.
- 2After 6 months, the enlicitide group’s LDL cholesterol dropped by 58.2% compared to placebo.
- 3Their other bad fats like non-HDL cholesterol, apolipoprotein B, and lipoprotein(a) also dropped a lot.
- 4The good news is the effect lasted a full year.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
JAMA
Year
2025
Authors
Christie M. Ballantyne, Laura A Gellis, J. Tardif, Puja Banka, A. Navar, E. A. Asprusten, Russell Scott, E. Stroes, Samar Froman, G. Mendizabal, Fan Wang, A. Catapano
Related Content
Claims (6)
For adults with a genetic cholesterol problem who are already on cholesterol meds, taking a pill called enlicitide every day for 6 months might drastically lower a key heart disease risk protein in their blood.
For people with a genetic cholesterol problem who are already on cholesterol pills, taking a new drug called enlicitide every day for 6 months might slash their bad cholesterol way more than just the usual treatment alone.
For people with a genetic cholesterol problem who are already on cholesterol meds, taking a pill called enlicitide every day for a year keeps their bad cholesterol way down — cutting it by more than half — while those not taking it see their levels go up.
For adults with a genetic cholesterol problem and already taking statins, adding a pill called enlicitide every day for 6 months slashed bad cholesterol levels by over half, while a fake pill barely changed anything.
For adults with a genetic cholesterol problem who are already taking cholesterol pills, adding a daily 20 mg pill called enlicitide for 6 months cuts a harmful type of blood fat (lipoprotein(a)) by about a quarter—way more than a dummy pill does.
Oral PCSK9 inhibitors can achieve approximately 58% reduction in LDL cholesterol, offering a non-injectable alternative to monoclonal antibody therapies.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.